...
首页> 外文期刊>Pediatric Pulmonology >Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
【24h】

Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).

机译:比较新生儿筛查出的囊性纤维化的临床进展与根据临床症状诊断出的囊性纤维化的进展:在法国地区(布列塔尼)进行的一项为期十年的回顾性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Until the year 2000, systematic cystic fibrosis (CF) neonatal screening was only performed in a few regions of France. The Brittany region began in 1989, but not the neighboring region of Loire-Atlantique. The present study compares the clinical evolution of both affected populations 10 years after screening was started. Although the 77 screened and 36 nonscreened children were followed in different CF centers, they were included in similar care protocols. The clinical characteristics at diagnosis and their evolution over a 10-year period of all the children affected with CF and born between January 1, 1989 and December 31, 1998, excluding those with meconium ileus, were compared. There were no significant differences in sex ratio, gestational age, anthropometric data at birth, frequency of deltaF508 homozygotes, proportion of pancreatic-insufficient patients, and mean age between the two populations. Age at diagnosis was lower in the screened group (38 days vs. 472 days, P < 10(-7)), as was the delay in supplementation with pancreatic enzymes (1.7 months vs.15.9 months, P < 10(-7)). The proportion of children who were hospitalized at least once was higher among the nonscreened than the screened patients (86% vs. 49%, P < 10(-4)). Z-scores for weight and height were significantly better in the screened population, not only in the first years of life, but also at 5 years old for height and 8 years old for weight. The Shwachman and Brasfield scores were higher among the screened children during the whole period of follow-up. No significant differences in colonization by Pseudomonas aeruginosa nor in lung function were found. Given the homogeneity in the characteristics and the follow-up of both populations, the benefits in terms of nutrition and clinical well-being of neonatal screening appear to be clear, thus confirming the advantages of its general implementation.
机译:直到2000年,仅在法国的一些地区进行了系统性囊性纤维化(CF)新生儿筛查。布列塔尼地区始于1989年,但邻近的卢瓦尔-亚特兰提克地区除外。本研究比较了开始筛查10年后两个受影响人群的临床进展。尽管在不同的CF中心对77名接受过筛查的儿童和36名未经筛查的儿童进行了追踪,但他们仍被包括在类似的照护方案中。比较了1989年1月1日至1998年12月31日之间出生的所有受CF影响的儿童(不包括胎粪肠梗阻)的诊断时的临床特征及其在10年内的演变。在这两个人群之间,性别比,胎龄,出生时的人体测量学数据,deltaF508纯合子的频率,胰腺功能不全患者的比例以及平均年龄均无显着差异。筛查组的诊断年龄较低(38天vs 472天,P <10(-7)),以及补充胰酶的延迟时间(1.7个月vs. 15.9个月,P <10(-7)) )。非筛查患者中至少住院一次的儿童比例高于筛查患者(86%比49%,P <10(-4))。在被筛查人群中,体重和身高的Z评分显着提高,不仅在生命的最初几年,而且在身高5岁和体重8岁时。在整个随访期间,被筛查的儿童中Shwachman和Brasfield得分较高。铜绿假单胞菌定植或肺功能均无显着差异。考虑到两个人群的特征和随访均一性,新生儿筛查在营养和临床健康方面的好处似乎很明显,因此证实了其总体实施的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号